Boston's InSpire MD Eyes $24.8 Million Series C Round Post author:Sam Post published:January 25, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Genentech's $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire February 6, 2017 Keryx, Norwich Pharma Mutually Terminate Manufacturing Agreement December 27, 2017 Ethicon Release: Company Announces Acquisition Of MEGADYNE January 19, 2017